Kaltenbach TE, Engler P, Kratzer W, Oeztuerk S, Seufferlein T, Haenle MM et al (2016) Prevalence of benign focal liver lesions: ultrasound investigation of 45,319 hospital patients. Abdom Radiol (NY) 41(1):25–32
Article
Google Scholar
European Association for the Study of the Liver (2016) EASL clinical practice guidelines on the management of benign liver tumours. J Hepatol 65(2):386–398
Ishak KG, Rabin L (1975) Benign tumors of the liver. Med Clin North Am 59(4):995–1013
Article
CAS
Google Scholar
Karhunen PJ (1986) Benign hepatic tumours and tumour like conditions in men. J Clin Pathol 39(2):183–188
Article
CAS
Google Scholar
Rodríguez-Peláez M, Menéndez De Llano R, Varela M (2010) Benign liver tumors. Gastroenterol Hepatol 33(5):391–397
Article
Google Scholar
Carrim ZI, Murchison JT (2003) The prevalence of simple renal and hepatic cysts detected by spiral computed tomography. Clin Radiol 58(8):626–629
Article
CAS
Google Scholar
Stoot JH, Coelen RJ, De Jong MC, Dejong CH (2010) Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB (Oxford) 12(8):509–522
Article
Google Scholar
Deneve JL, Pawlik TM, Cunningham S, Clary B, Reddy S, Scoggins CR et al (2009) Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancy. Ann Surg Oncol 16(3):640–648
Article
Google Scholar
Rooks JB, Ory HW, Ishak KG, Strauss LT, Greenspan JR, Hill AP et al (1979) Epidemiology of hepatocellular adenoma: the role of oral contraceptive use. JAMA 242(7):644–648
Article
CAS
Google Scholar
Marrero JA, Ahn J, Rajender Reddy K (2014) ACG clinical guideline: the diagnosis and management of focal liver lesions. Am J Gastroenterol 109(9):1328–1347
Article
Google Scholar
van Rosmalen BV, Coelen RJS, Bieze M, van Delden OM, Verheij J, Dejong CHC et al (2017) Systematic review of transarterial embolization for hepatocellular adenomas. Br J Surg 104(7):823–835
Article
Google Scholar
Furumaya A, van Rosmalen BV, Takkenberg RB, van Delden OM, Dejong CHC, Verheij J et al (2019) Transarterial (chemo-)embolization and lipiodolization for hepatic haemangioma. Cardiovasc Intervent Radiol 42(6):800–811
Article
Google Scholar
van Rosmalen BV, Klompenhouwer AJ, de Graeff JJ, Haring MPD, de Meijer VE, Rifai L et al (2019) Safety and efficacy of transarterial embolization of hepatocellular adenomas. Br J Surg 106(10):1362–1371
Article
Google Scholar
Furumaya A, van Rosmalen BV, de Graeff JJ, Haring MPD, de Meijer VE, van Gulik TM et al (2021) Systematic review on percutaneous aspiration and sclerotherapy versus surgery in symptomatic simple hepatic cysts. HPB (Oxford) 23(1):11–24
Article
Google Scholar
Weldring T, Smith SMS (2013) Patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs). Health Serv Insights 6:61–68
Google Scholar
Montgomery N, Howell D, Ismail Z, Bartlett SJ, Brundage M, Bryant-Lukosius D et al (2020) Selecting, implementing and evaluating patient-reported outcome measures for routine clinical use in cancer: the Cancer Care Ontario approach. J Patient Rep Outcomes 4(1):101
Article
Google Scholar
Cella D, Riley W, Stone A, Rothrock N, Reeve B, Yount S et al (2010) The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008. J Clin Epidemiol 63(11):1179–1194
Article
Google Scholar
Field J, Holmes MM, Newell D (2019) PROMs data: can it be used to make decisions for individual patients? A narrative review. Patient Relat Outcome Meas 10:233–241
Article
Google Scholar
Gibbons C, Porter I, Gonçalves-Bradley DC, Stoilov S, Ricci-Cabello I, Tsangaris E et al (2021) Routine provision of feedback from patient-reported outcome measurements to healthcare providers and patients in clinical practice. Cochrane Database Syst Rev 10(10):Cd011589
Google Scholar
Turney L, Pocknee C (2005) Virtual focus groups: new frontiers in research. Int J Qual Methods 4(2):32–43
Article
Google Scholar
Dos Santos Marques IC, Theiss LM, Johnson CY, McLin E, Ruf BA, Vickers SM et al (2021) Implementation of virtual focus groups for qualitative data collection in a global pandemic. Am J Surg 221(5):918–922
Article
Google Scholar
Khan M, Hanif F, Syed AA (2017) Surgical management for symptomatic giant liver hemangiomas: a meta-analysis. J Coll Physicians Surg Pak 27(3):173–182
Google Scholar
Perrakis A, Vassos N, Grützmann R, Croner RS (2017) What is changing in indications and treatment of focal nodular hyperplasia of the liver. Is there any place for surgery? Ann Hepatol 16(3):333–341
Article
Google Scholar
Yedibela S, Alibek S, Müller V, Aydin U, Langheinrich M, Lohmüller C et al (2013) Management of hemangioma of the liver: surgical therapy or observation? World J Surg 37(6):1303–1312
Article
Google Scholar
Hau HM, Atanasov G, Tautenhahn HM, Ascherl R, Wiltberger G, Schoenberg MB et al (2015) The value of liver resection for focal nodular hyperplasia: resection yes or no? Eur J Med Res 20:86
Article
Google Scholar
Orozco H, Mercado MA, Hinojosa CA (2001) Evaluation of 20 years of experience and quality of life in patients surgically treated for liver cystic disease. Rev Gastroenterol Mex 66(4):179–186
CAS
Google Scholar
Wijnands TF, Gevers TJ, Kool LJ, Drenth JP (2015) Aspiration sclerotherapy combined with pasireotide to improve reduction of large symptomatic hepatic cysts (SCLEROCYST): study protocol for a randomized controlled trial. Trials 16:82
Article
Google Scholar
Gall TM, Oniscu GC, Madhavan K, Parks RW, Garden OJ (2009) Surgical management and longterm follow-up of non-parasitic hepatic cysts. HPB (Oxford) 11(3):235–241
Article
Google Scholar
Schnelldorfer T, Ware AL, Smoot R, Schleck CD, Harmsen WS, Nagorney DM (2010) Management of giant hemangioma of the liver: resection versus observation. J Am Coll Surg 211(6):724–730
Article
Google Scholar
Kamphues C, Engel S, Denecke T, Bova R, Hippler-Benscheidt M, Puhl G et al (2011) Safety of liver resection and effect on quality of life in patients with benign hepatic disease: single center experience. BMC Surg 11:16
Article
Google Scholar
Kneuertz PJ, Marsh JW, de Jong MC, Covert K, Hyder O, Hirose K et al (2012) Improvements in quality of life after surgery for benign hepatic tumors: Results from a dual center analysis. Surgery 152(2):193–201
Article
Google Scholar
van Aalten SM, Bröker ME, Busschbach JJ, de Koning HJ, de Man RA, Steegers EA et al (2012) Pregnancy and liver adenoma management: PALM-study. BMC Gastroenterol 12:82
Article
Google Scholar
Scheuerlein H, Rauchfuss F, Franke J, Jandt K, Dittmar Y, Trebing G et al (2013) Clinical symptoms and sonographic follow-up after surgical treatment of nonparasitic liver cysts. BMC Surg 13:42
Article
Google Scholar
Qiu J, Chen S, Wu H (2015) Quality of life can be improved by surgical management of giant hepatic haemangioma with enucleation as the preferred option. HPB (Oxford) 17(6):490–494
Article
Google Scholar
Klompenhouwer AJ, Sprengers D, Willemssen FE, Gaspersz MP, Ijzermans JN, De Man RA (2016) Evidence of good prognosis of hepatocellular adenoma in post-menopausal women. J Hepatol 65(6):1163–1170
Article
Google Scholar
van Rosmalen BV, Bieze M, Besselink MG, Tanis P, Verheij J, Phoa SS et al (2016) Long-term outcomes of resection in patients with symptomatic benign liver tumours. HPB (Oxford) 18(11):908–914
Article
Google Scholar
Kisiel A, Vass DG, Navarro A, John AK, Isaac J, Marudanayagam R et al (2017) Long-term patient-reported outcomes after laparoscopic fenestration of symptomatic liver cysts. Surg Laparosc Endosc Percutan Tech 27(4):e80–e82
Article
Google Scholar
de Reuver P, van der Walt I, Albania M, Samra JS, Hugh TJ (2018) Long-term outcomes and quality of life after surgical or conservative treatment of benign simple liver cysts. Surg Endosc 32(1):105–113
Article
Google Scholar
Janssen YF, Haring MPD, Bastiaannet E, Patijn GA, Klaase JM, de Boer MT et al (2020) Surgical treatment for non-parasitic liver cysts improves quality of life. Surgeon 18:257–264
Article
Google Scholar
Liu Q, Liu F, Ding J, Wei Y, Li B (2019) Surgical outcomes and quality of life between laparoscopic and open approach for hepatic hemangioma: a propensity score matching analysis. Medicine (Baltimore) 98(6):e14485
Article
Google Scholar
Wijnands TFM, Gevers TJG, Lantinga MA, Te Morsche RH, Schultze Kool LJ, Drenth JPH (2018) Pasireotide does not improve efficacy of aspiration sclerotherapy in patients with large hepatic cysts, a randomized controlled trial. Eur Radiol 28(6):2682–2689
Article
Google Scholar
Neijenhuis MK, Wijnands TFM, Kievit W, Ronot M, Gevers TJG, Drenth JPH (2019) Symptom relief and not cyst reduction determines treatment success in aspiration sclerotherapy of hepatic cysts. Eur Radiol 29(6):3062–3068
Article
Google Scholar
Armstrong EA, Ejaz A, Sarna A, Conteh L, Tsung A, Pawlik TM et al (2020) A cross-sectional evaluation of quality of life among patients with hepatic adenomas. J Gastrointest Surg 24(12):2862–2864
Article
Google Scholar
Xu S, Rao M, Pu Y, Zhou J, Zhang Y (2020) The efficacy of laparoscopic lauromacrogol sclerotherapy in the treatment of simple hepatic cysts located in posterior segments: a refined surgical approach. Ann Palliat Med 9(5):3462–3471
Article
Google Scholar
Loehe F, Globke B, Marnoto R, Bruns CJ, Graeb C, Winter H, et al (2010) Long-term results after surgical treatment of nonparasitic hepatic cysts. Am J Surg 200(1):23–31
Article
CAS
Google Scholar
Ali Metwally AM, Zaghloul NM, Ali MM, Hafez AS, Abdelfattah AS (2020) Evaluation of laparoscopic resection of hepatic focal lesions, short term outcome. Indian J Public Health Res Dev 11(5):603–607
Google Scholar
Segawa E, Schalet B, Cella D (2020) A comparison of computer adaptive tests (CATs) and short forms in terms of accuracy and number of items administrated using PROMIS profile. Qual Life Res 29(1):213–221
Article
Google Scholar
Hung M, Stuart AR, Higgins TF, Saltzman CL, Kubiak EN (2014) Computerized adaptive testing using the PROMIS physical function item bank reduces test burden with less ceiling effects compared with the short musculoskeletal function assessment in orthopaedic trauma patients. J Orthop Trauma 28(8):439–443
Article
Google Scholar
Montgomery N, Howell D, Ismail Z, Bartlett SJ, Brundage M, Bryant-Lukosius D et al (2020) Selecting, implementing and evaluating patient-reported outcome measures for routine clinical use in cancer: the Cancer Care Ontario approach. J Patient Rep Outcomes 4(1):101
Article
Google Scholar
Terwee CB, Roorda LD, de Vet HC, Dekker J, Westhovens R, van Leeuwen J et al (2014) Dutch–Flemish translation of 17 item banks from the patient-reported outcomes measurement information system (PROMIS). Qual Life Res 23(6):1733–1741
CAS
Google Scholar
Terwee CB, Zuidgeest M, Vonkeman HE, Cella D, Haverman L, Roorda LD (2021) Common patient-reported outcomes across ICHOM Standard Sets: the potential contribution of PROMIS®. BMC Med Inform Decis Mak 21(1):259
Article
Google Scholar
Schalet BD, Lim S, Cella D, Choi SW (2021) Linking scores with patient-reported health outcome instruments: a validation study and comparison of three linked methods. Psychometrika 86(3):717–746
Article
Google Scholar
Furumaya A, Haring MPD, van Rosmalen BV, Klompenhouwer AJ, Besselink MG, de Man RA, et al (2022) Study protocol for a multicentre nationwide prospective cohort study to investigate the natural course and clinical outcome in benign liver tumours and cysts in the Netherlands: the BELIVER study. BMJ Open 12(9):e055104
Article
Google Scholar
Damman OC, Jani A, de Jong BA, Becker A, Metz MJ, de Bruijne MC et al (2020) The use of PROMs and shared decision-making in medical encounters with patients: An opportunity to deliver value-based health care to patients. J Eval Clin Pract 26(2):524–540
Article
Google Scholar
Bingham CO, Bartlett SJ, Merkel PA, Mielenz TJ, Pilkonis PA, Edmundson L et al (2016) Using patient-reported outcomes and PROMIS in research and clinical applications: experiences from the PCORI pilot projects. Qual Life Res 25(8):2109–2116
Article
Google Scholar